TOP1288
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TOP1288, covering 2017-05-23 to 2017-07-07. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis [Phase 2]